Lannett, Cediprof ink distribution deal for Synthroid genericLevothyroxine sodium tablets had a market value of approximately $2.3 billion for the 12 months ended May 2020, according to IQVIA. FDA commissioner to speak at public meeting on GDUFA reauthorizationThe Generic Drug User Fee Amendment III public meeting agenda will include a keynote address by FDA Commissioner Stephen Hahn and presentations by FDA staff and stakeholder groups, as well as public comment. Cipla receives FDA OK for generic Firazyr Firazyr and its generic equivalents had a market value of approximately $270 million for the 12-month period ended May 2020, according to IQVIA. Teva intros ProAir Digihaler Teva's ProAir Digihaler is the first and only digital rescue inhaler indicated in patients 4 years old and older for the treatment or prevention of bronchospasm who have reversible obstructive airway disease. Strides Pharma obtains FDA nod for generic Fioricet Butalbital, acetaminophen, caffeine and codeine phosphate capsules had a market value of roughly $10 million, according to IQVIA May 2020 data. Lannett restructures, cuts jobs Lannett said it expects its restructuring, consolidation plan and workforce cuts will save more than $15 million annually. Amneal launches generic Prolixin Fluphenazine hydrochloride tablets had a market value of roughly $143 million for the 12 months ended May 2020, according to IQVIA. Mylan, Fujifilm Kyowa Kirin Biologics obtain FDA nod for Humira biosimilar Hulio, a biosimilar to Humira, is expected to be launched in July 2023. Alembic intros generic Almirall Alembic's generic Almirall is available in dosage strengths of 75 mg and 150 mg. ANI acquires generic Diflucan Fluconazole tablets had a market value of approximately $40 million, according to IQVIA. First Previous 153 154 155 156 157 Next Last
